Nura Bio

Nura Bio, formerly known as Proneurotech Inc., is a biotechnology company based in South San Francisco, California. The company has 23 employees. Nura Bio focuses on developing transformative neuroprotective therapies to prevent and protect against neuronal loss and related neuroimmune dysregulation. Their research and development strategy centers on two approaches: preventing neuronal loss to preserve neurological function and restoring the function of the neuron-glia axis to improve the nervous system’s immune surveillance capacity in response to neurological injury. The company's discovery engine and multi-target pipeline span these approaches, aiming to address a broad range of neurological diseases. Nura Bio's lead program is focused on SARM1 inhibitors. SARM1, a newly identified axon-intrinsic metabolic sensor, plays a pivotal role in axonal degeneration and neuronal integrity. For more information, visit nurabio.com.